Skip to main content
. 2008 Jan 10;57(6):759–775. doi: 10.1007/s00262-007-0445-6

Fig. 2.

Fig. 2

E-cadherin is released from Colo 205 cells as they undergo Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Cells were treated with 250 ng/ml Apo2L/TRAIL for 2, 4, 8, and 16 h. Cell culture media was collected and E-cadherin was immunoprecipitated from the samples and then detected on a western blot with the HECD-1 clone. C control, T Apo2L/TRAIL-treated